Ratio of Tumor Activity to Whole-Body Activity at 24 Hours After Injection
| Patient no. | Diagnostics, intravenous | Therapy, intravenous | Ratio | Diagnostics, intravenous | Therapy, intraarterial | Ratio |
|---|---|---|---|---|---|---|
| 1 | 12.09 | 10.1 | 0.84 | 13.19 | 15.05 | 1.14 |
| 2 | 1.13 | 1.57 | 1.39 | |||
| 3* | 11.43 | 10.25 | 0.90 | 9.78 | 17.20 | 1.76 |
| 4* | 9.06 | 8.75 | 0.97 | 8.44 | 10.21 | 1.21 |
| 5 | 3.99 | 6.41 | 1.61 | |||
| 6 | 8.41 | 16.18 | 1.92 | |||
| 7 | 41.55 | 44.40 | 1.07 | |||
| 8* | 2.43 | 2.67 | 1.10 | 2.04 | 3.88 | 1.90 |
| 9* | 2.47 | 2.62 | 1.06 | 1.01 | 4.53 | 4.48 |
| 10 | 0.47 | 0.62 | 1.30 | |||
| 11* | 2.07 | 1.28 | 0.62 | 1.03 | 1.05 | 1.01 |
| 12 | 1.32 | 1.08 | 0.81 | 1.46 | 1.81 | 1.24 |
| 13* | 1.64 | 1.63 | 0.99 | 1.36 | 2.69 | 1.99 |
| 14 | 6.35 | 6.28 | 0.99 | 5.13 | 10.25 | 2.00 |
| 15* | 1.26 | 1.47 | 1.17 | 4.69 | 5.16 | 1.10 |
| 16* | 1.52 | 1.59 | 1.04 | 1.71 | 1.47 | 0.86 |
| 17 | 1.63 | 1.59 | 0.97 | 1.47 | 4.10 | 2.97 |
| Mean ± SD | 4.44 ± 4.16 | 4.11 ± 3.66 | 0.96 ± 0.15 | 6.26 ± 9.85 | 8.62 ± 10.72 | 1.69 ± 0.87 |
↵* Patients who received intraarterial treatment before intravenous therapy.